Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High-Risk Gastric/Gastroesophageal Junction Cancer.
Liu Q, Chu Y, Shao J, Qian H, Yang J, Sha H, Cen L, Tian M, Xu Q, Chen F, Yang Y, Wang W, Wang K, Yu L, Wei J, Liu B.
Liu Q, et al. Among authors: liu b.
Adv Sci (Weinh). 2022 Nov 9;10(1):e2203298. doi: 10.1002/advs.202203298. Online ahead of print.
Adv Sci (Weinh). 2022.
PMID: 36351249
Free PMC article.